Daiichi Sankyo Company Limited (DSKYF,4568.T), a Japanese pharmaceutical company, said on Monday that it expects a rise in earnings and revenue for the full year, supported by increased revenue from Enhertu, Datroway, and others.
For the 12-month period to March 31, 2027, the company expects a net income of JPY 260 billion, with an operating profit of JPY 315 billion, on revenue of JPY 2.280 trillion.
For the 12-month period to March 31, 2026, Daiichi Sankyo has recorded a net profit of JPY 259.874 billion, with an operating income of JPY 229.089 billion, on revenue of JPY 2.123 trillion.
For the 12-month period to March 31, 2027, the company plans to pay a total dividend of JPY 100 per share, up from JPY 78 per share in the previous year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.